Last updated: 07/04/2026, 10:59

Welcome to this week’s Medicinal Cannabis Matters, where we bring together the latest developments shaping medicinal cannabis in the UK and beyond. This week highlights a growing industry, where patient stories and market growth all point towards a more established and better understood treatment landscape.

Welcome to this week’s Medicinal Cannabis Matters, where we bring together the latest patient stories, research and policy developments shaping medicinal cannabis care. This week’s updates highlight a clear and encouraging trend with growing patient confidence, expanding evidence and continued progress in how cannabis-based treatments are understood and delivered.

Welcome to this week’s Medicinal Cannabis Matters, where we explore the latest conversations shaping medicinal cannabis care in the UK and beyond. This week’s stories reflect the important shift happening, where society moves beyond broad assumptions towards more patient-centred understanding, particularly in areas such as mental health, women’s health and international regulation.

Welcome to this week’s Medicinal Cannabis Matters, where we highlight the latest developments shaping medicinal cannabis care in the UK and beyond. From patient protection initiatives to emerging research and the role cannabis may play in addressing wider healthcare challenges, the conversation continues to evolve as awareness and understanding grow.

Each week, the conversation around medicinal cannabis continues to grow as new patient stories, research and policy discussions highlight how this treatment is changing lives. From individuals managing long-term conditions to campaigns pushing for greater awareness and access, the evidence and experiences emerging across the UK continue to shape the future of care. This week’s roundup explores a powerful patient story about living with multiple sclerosis, how medicinal cannabis has helped manage a chronic skin condition and a campaign honouring the legacy of Hannah Deacon, a dear friend of Medicann’s, who played a role in changing UK cannabis law.

This week’s Medicinal Cannabis Matters brings together developments in patient education, regulatory accountability and international market recovery. From practical guidance on pain relief for arthritis to important conversations about clinical responsibility, the wider landscape continues to mature in both structure and understanding.